141 related articles for article (PubMed ID: 29808805)
1. MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.
Peng Z; Zhu W; Dai J; Ju F
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):77-85. PubMed ID: 29808805
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
Liu T; Yin L; Yan G; Li C; Wang L
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
Liu T; Liu D; Guan S; Dong M
Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
[TBL] [Abstract][Full Text] [Related]
6. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
8. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
[TBL] [Abstract][Full Text] [Related]
10. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
[TBL] [Abstract][Full Text] [Related]
12. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
14. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
15. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
18. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.
Baraniskin A; Nöpel-Dünnebacke S; Ahrens M; Jensen SG; Zöllner H; Maghnouj A; Wos A; Mayerle J; Munding J; Kost D; Reinacher-Schick A; Liffers S; Schroers R; Chromik AM; Meyer HE; Uhl W; Klein-Scory S; Weiss FU; Stephan C; Schwarte-Waldhoff I; Lerch MM; Tannapfel A; Schmiegel W; Andersen CL; Hahn SA
Int J Cancer; 2013 Jan; 132(2):E48-57. PubMed ID: 22907602
[TBL] [Abstract][Full Text] [Related]
19. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
Hao JP; Ma A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
